Ophthalmic rosacea in a patient with Takayasu disease

Sameh Sayhi1, Sameh Mezri2, Nadia Ben Abdelhafidh1

1Internal Medicine Department, Military Hospital of Tunis, Tunis, Tunisia2ENT Surgery Department, Military Hospital of Tunis, Tunis, Tunisia

Corresponding author: Dr. Sameh Sayhi, E-mail: sameh_sayhi@yahoo.fr

Submission: 20.05.2019; Acceptance: 25.08.2019


Cite this article: Sayhi S, Mezri S, Ben Abdelhafi dh N. Ophthalmic rosacea in a patient with Takayasu disease. Our Dermatol Online. 2020;11(1):83.

Citation tools: 

BibTex  |  CSV   |  RIS  |  Endnote XML

Related Content

Copyright information
© Our Dermatology Online 2019. No commercial re-use. See rights and permissions. Published by Our Dermatology Online.

Rosacea is a chronic dermatological disease that may affect the ocular structures up to 6-72% [1] of all cases with important visual consequences for affected patients. Therefore, an early diagnosis associated with adequate treatment is important [2].

The aim of this study is to report an original observation of ophthalmic rosacea in a patient with Takayasu disease.

We report the case of 49-year-old women with Takayasu disease treated by methotrexate 20mg/day who consulted for eye redness, tearing, and decreased visual acuity. The ophthalmological examination revealed a visual acuity (VA) of 9/10, keratoconjunctivitis + blepharitis (Fig. 1). He was diagnosed with ocular rosacea and treated with doxycycline and topical tacrolimus cream.

Figure 1: Blephartis and conjonctivitis in patient with rosacea.                                  

Ocular rosacea includes multiple ophthalmic manifestations ranging from inflammation of the eyelid margin and blepharitis to serious corneal affectations. An early diagnosis associated with adequate treatment visual allows avoiding sequelae.


1. Vieira AC, Höfling-Lima AL, Mannis MJ. Ocular rosacea-a review. Arq Bras Oftalmol. 2012;75:363–9.

2. Gloria López-Valverde, Elena Garcia-Martin, Jos, Manuel Larrosa Povés, Vicente Polo-Llorens, Luis E. Pablo-Júlvez. Therapeutical Management for ocular Rosacea. Case Rep Ophthalmol. 2016;7:237–42.


Source of Support: Nil,

Conflict of Interest: None declared.

Request permissions
If you wish to reuse any or all of this article please use the e-mail (brzezoo77@yahoo.com) to contact with publisher.

Related Content:

Related Articles Search Authors in





Other Resources

Our Dermatology Online

Current Issue
All Issues
Instruction for authors
Submit Manuscripts
Ethics in Publishing
For Reviewers
Editors & Publishers 
Contact Us